Stride (LRN)
(Delayed Data from NYSE)
$68.58 USD
+1.06 (1.57%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $68.59 +0.01 (0.01%) 5:24 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$68.58 USD
+1.06 (1.57%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $68.59 +0.01 (0.01%) 5:24 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
3 School Stocks Trying to Survive Industry Challenges
by Shrabana Mukherjee
Economic slowdown may create hurdles for the Zacks Schools industry. Meanwhile, virtual delivery of education along with prudent cost-saving initiatives will open up opportunities for LRN, PEI and LOPE.
Adtalem's (ATGE) Stock Up on Q1 Earnings & Revenue Beat
by Zacks Equity Research
Adtalem Global Education (ATGE) reports solid first-quarter fiscal 2021 results, given higher revenues and strong margins.
Marriott Vacations (VAC) Q3 Earnings Miss Estimates, Fall Y/Y
by Zacks Equity Research
Marriott Vacations' (VAC) third-quarter top-line results are negatively impacted by lower occupancy rates on account of the pandemic.
JAKKS Pacific (JAKK) Q3 Earnings Beat Estimates, Decline Y/Y
by Zacks Equity Research
JAKKS Pacific's (JAKK) third-quarter top line was hurt by dismal sales of products related to Disney's Frozen and Frozen 2 as well as Disguise Halloween costumes.
LRN vs. BFAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LRN vs. BFAM: Which Stock Is the Better Value Option?
Has K12 (LRN) Outpaced Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (LRN) Outperforming Other Consumer Discretionary Stocks This Year?
Top Ranked Growth Stocks to Buy for October 30th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, October 30th
New Strong Buy Stocks for October 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today.
K12 (LRN) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
K12 (LRN) delivered earnings and revenue surprises of 188.24% and 1.64%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Factors Setting the Tone for K12 (LRN) This Earnings Season
by Zacks Equity Research
Higher demand for online learning options is likely to have supported K12's (LRN) fiscal Q1 revenues. However, acquisition-related costs and lower institutional sales may have been concerns.
Analysts Estimate K12 (LRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
K12 (LRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Reasons Growth Investors Will Love K12 (LRN)
by Zacks Equity Research
K12 (LRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Is K12 (LRN) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (LRN) Outperforming Other Consumer Discretionary Stocks This Year?
K12 Enters Oversold Territory
by Zacks Equity Research
K12 has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
The Zacks Analyst Blog Highlights: YETI Holdings, Malibu Boats, NIKE, K12 and Activision Blizzard
by Zacks Equity Research
The Zacks Analyst Blog Highlights: YETI Holdings, Malibu Boats, NIKE, K12 and Activision Blizzard
3 Stocks in Focus on the Massive Shift to Online Learning
by Tuhin Roy
A significant surge has been witnessed in the use of online education tools since the onset of the pandemic and with no signs of the pandemic abating, the trend is likely to continue.
Solid Consumer Confidence Confirms Economic Stability: 5 Picks
by Nalak Das
A jump in consumer confidence in September amid severe volatility in stock markets and lack of a fresh stimulus is a bright sign for the U.S. economy.
LRN vs. BFAM: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LRN vs. BFAM: Which Stock Is the Better Value Option?
Is K12 (LRN) Outperforming Other Consumer Discretionary Stocks This Year?
by Zacks Equity Research
Is (LRN) Outperforming Other Consumer Discretionary Stocks This Year?
Here is Why Growth Investors Should Buy K12 (LRN) Now
by Zacks Equity Research
K12 (LRN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks.com featured highlights include: K12, DICK'S Sporting Goods, SPX Corporation, Etsy and AGCO Corporation
by Zacks Equity Research
Zacks.com featured highlights include: K12, DICK'S Sporting Goods, SPX Corporation, Etsy and AGCO Corporation
5 Stocks With Upgraded Broker Ratings Worth Investing in Now
by Swayta Shah
One can easily choose stocks with steady, profitable returns by following broker upgrades.
4 Education Stocks to Gain on Growing Demand for Online Classes
by Ritujay Ghosh
Although schools are gradually opening, an increasing number of teachers and students prefer online education for fears of getting infected by the virus.
K12 Enters Oversold Territory
by Zacks Equity Research
K12 has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
LRN vs. UTI: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LRN vs. UTI: Which Stock Is the Better Value Option?